Skip to main content
OpenTrials
Completed

NCT Number: NCT02261337

Is Gait Speed and Sarcopenia Prognostic in Chronic Respiratory Disease?

This study aims to assess usual walking speed (4-metre gait speed) and markers of sarcopenia predict mortality in patients with chronic respiratory disease.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Chronic Obstructive Pulmonary Disease and Allied Conditions Atrophy Chronic Disease Disease Attributes Lung Diseases Lung Diseases, Obstructive Muscular Atrophy Nervous System Diseases Neurologic Manifestations Neuromuscular Manifestations Pathologic Processes Pathological Conditions, Anatomical Pathological Conditions, Signs and Symptoms Pulmonary Disease, Chronic Obstructive Respiratory Tract Diseases Sarcopenia Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Harefield hospital

Harefield, Middlesex, UB96JH, United Kingdom

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All patients with chronic respiratory disease who are able to complete the assessments.

Exclusion criteria

  • Significant co-morbidities that would limit walking ability, exercise capacity or make exercise unsafe (e.g. unstable ischaemic heart disease, neuromuscular disease, severe hip/lower limb joint pain, peripheral vascular disease, lower limb amputation).
  • Any patient whom the Chief Investigator feels it is unsafe to exercise (e.g. unstable cardiovascular disease).

Treatment and study plan

Primary outcomes

  1. Number of participant deaths

    Time frame: 1 year

Secondary outcomes

  1. Number of participant deaths

    Time frame: 2 years and 5 years

  2. Number of exacerbations as defined by a worsening of symptoms that warrant a change in medication.

    Time frame: 1 and 2 years

  3. Number of hospital admissions

    Time frame: 1 and 2 years

  4. Number of patients admitted to a nursing home

    Time frame: 2 and 5 years

  5. Number of hospital bed days

    Time frame: 1 and 2 years

Sponsors and collaborators

Lead sponsor

Royal Brompton & Harefield NHS Foundation Trust

Other

Collaborators

  • Medical Research Council

Registry information

Official study title

Do Gait Speed and Markers of Sarcopenia Predict Prognosis in Patients With Chronic Respiratory Disease?

Important dates

Study start
2013
Primary completion
2018
Study completion
2022
First posted
Oct 10, 2014
Registry last updated
Nov 1, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.